MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with E

Erlotinib

Erlotinib 25mg tablets

No stability information

Stability notes for Erlotinib 25mg tablets

There are no stability notes for this medicine.

Suppliers (4) of Erlotinib 25mg tablets
Erlotinib 25mg tablets (A A H Pharmaceuticals Ltd)
Erlotinib 25mg tablets (Alliance Healthcare (Distribution) Ltd)
Erlotinib 25mg tablets (Amarox Ltd)
Erlotinib 25mg tablets (Glenmark Pharmaceuticals Europe Ltd)

Erlotinib 100mg tablets

No stability information

Stability notes for Erlotinib 100mg tablets

There are no stability notes for this medicine.

Suppliers (6) of Erlotinib 100mg tablets
Erlotinib 100mg tablets (A A H Pharmaceuticals Ltd)
Erlotinib 100mg tablets (Accord-UK Ltd)
Erlotinib 100mg tablets (Amarox Ltd)
Erlotinib 100mg tablets (Glenmark Pharmaceuticals Europe Ltd)
Erlotinib 100mg tablets (Teva UK Ltd)
Tarceva 100mg tablets (Neon Healthcare Ltd)

Erlotinib 150mg tablets

No stability information

Stability notes for Erlotinib 150mg tablets

There are no stability notes for this medicine.

Suppliers (5) of Erlotinib 150mg tablets
Erlotinib 150mg tablets (A A H Pharmaceuticals Ltd)
Erlotinib 150mg tablets (Accord-UK Ltd)
Erlotinib 150mg tablets (Alliance Healthcare (Distribution) Ltd)
Erlotinib 150mg tablets (Amarox Ltd)
Erlotinib 150mg tablets (Glenmark Pharmaceuticals Europe Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.